How many stocks are there of Ceapro?
The current number of stocks of Ceapro is 78.27 M undefined.
Ceapro Stocks 2024
Ceapro Stocks
78.27 M
Ticker
CZO.V
ISIN
CA1499071076
WKN
931278
In 2024, Ceapro had 78.27 M outstanding stocks, a 0% change from the 78.27 M stocks in the previous year.
The Ceapro Stocks history
| YEAR | NUMBER OF STOCKS (undefined CAD) |
|---|---|
| 2024e | 78.27 |
| 2023 | 78.27 |
| 2022 | 78.58 |
| 2021 | 78.59 |
| 2020 | 78.14 |
| 2019 | 77.19 |
| 2018 | 76.2 |
| 2017 | 75.34 |
| 2016 | 71.33 |
| 2015 | 65.2 |
| 2014 | 60.9 |
| 2013 | 60.28 |
| 2012 | 60.28 |
| 2011 | 56.64 |
| 2010 | 58.22 |
| 2009 | 49.58 |
| 2008 | 47.05 |
| 2007 | 42.34 |
| 2006 | 37.19 |
| 2005 | 36.34 |
| 2004 | 34.76 |
Ceapro shares outstanding CA1499071076 · 931278
The number of shares was Ceapro in 2023 — This indicates how many shares 78.273 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
3 years
5 years
10 years
25 Years
Max
Number of stocks
Details
Revenue, EBIT and Earnings per share
ⓘRevenue Per Share
Revenue per share represents the total revenue Ceapro earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.
EBIT Per Share
EBIT per share indicates Ceapro's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.
Income Per Share
Income per share, or earnings per share (EPS), reveals the portion of Ceapro’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.
Expected Values
Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Ceapro's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.
| Number of stocks | |
|---|---|
| 2004 | 34.76 M Aktien |
| 2005 | 36.34 M Aktien |
| 2006 | 37.19 M Aktien |
| 2007 | 42.34 M Aktien |
| 2008 | 47.05 M Aktien |
| 2009 | 49.58 M Aktien |
| 2010 | 58.22 M Aktien |
| 2011 | 56.64 M Aktien |
| 2012 | 60.28 M Aktien |
| 2013 | 60.28 M Aktien |
| 2014 | 60.9 M Aktien |
| 2015 | 65.2 M Aktien |
| 2016 | 71.33 M Aktien |
| 2017 | 75.34 M Aktien |
| 2018 | 76.2 M Aktien |
| 2019 | 77.19 M Aktien |
| 2020 | 78.14 M Aktien |
| 2021 | 78.59 M Aktien |
| 2022 | 78.58 M Aktien |
| 2023 | 78.27 M Aktien |
| 2024e | 78.27 M Aktien |
Ceapro Aktienanalyse
What does Ceapro do?
Ceapro Inc is an innovative biotechnology company based in Edmonton, Canada. The company was founded in 1997 and has since specialized in the development of natural, biological ingredients from plants. It is listed on the Toronto Stock Exchange and has become a key player in the field of natural-based medicine and cosmetics in recent years. Ceapro's business model is based on the research and production of active compounds from plant-based raw materials. The company employs gentle extraction methods that preserve the effectiveness of the ingredients and enable environmentally friendly production. Ceapro collaborates closely with research and industry to ensure the best possible effectiveness and applicability of its products. The company's products are divided into various segments tailored to the needs of customers. One important segment is medicine, where Ceapro focuses on the development of herbal remedies. The company has already developed some promising products in this area, which can be used, for example, for inflammation, pain, or diabetes. Another important segment of Ceapro is cosmetics, where the company researches and produces natural ingredients for skin and hair care. These products are known for their high effectiveness, tolerability, and environmental friendliness. One of the company's most famous products is Avenanthramide, an ingredient derived from oats that offers anti-aging and anti-inflammatory properties. Ceapro also places special emphasis on the development of digestive-aid ingredients that can be used in the food industry. The company relies on plant enzymes and compounds that help support and relieve the digestive system. The use of natural ingredients ensures high tolerability and usability. Over the course of its history, Ceapro Inc has already won numerous awards and prizes that confirm the high quality of its products and the company's innovative power. For example, the company has been repeatedly honored with the Alberta Venture Fast Growth 50 Award and also received the Environmental Stewardship Award from the Edmonton Chamber of Commerce. Ceapro is not only an innovative biotechnology company specializing in the research and production of plant-based ingredients but also an important player in the fields of medicine and cosmetics. The company employs gentle extraction methods and collaborates closely with research and industry to achieve the best possible effectiveness and applicability. The different products are divided into the segments of medicine, cosmetics, and food and are known for their high effectiveness, tolerability, and environmental friendliness. Ceapro ist eines der beliebtesten Unternehmen auf Eulerpool.com.Stocks Details
Evaluating Ceapro's Shares Outstanding
Ceapro's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.
Year-to-Year Comparison
Tracking the changes in Ceapro’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.
Impact on Investments
For investors, understanding Ceapro’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.
Interpreting Changes in Shares Outstanding
Variances in Ceapro’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.
Frequently Asked Questions about Ceapro stock
What does Number of Shares / OutstandingShares mean?
The outstanding shares (or issued shares) of Ceapro are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.
How has the number of shares of Ceapro evolved in recent years?
The number of shares of Ceapro has increased by 0% gestiegen compared to last year.
What does the number of shares mean for investors?
The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.
Why does the number of stocks fluctuate?
There are various factors that can lead to a change. Ceapro as a company can issue new shares, carry out stock splits or reverse splits.
Does the number of shares have an impact on the performance of Ceapro?
There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
How much dividend does Ceapro pay?
Over the past 12 months, Ceapro paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Ceapro is expected to pay a dividend of 0 CAD.
What is the dividend yield of Ceapro?
The current dividend yield of Ceapro is .
When does Ceapro pay dividends?
Ceapro pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Ceapro?
Ceapro paid dividends every year for the past 0 years.
What is the dividend of Ceapro?
For the upcoming 12 months, dividends amounting to 0 CAD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Ceapro located?
Ceapro is assigned to the 'Commodities' sector.
Wann musste ich die Aktien von Ceapro kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Ceapro from 7/15/2024 amounting to 0 CAD, you needed to have the stock in your portfolio before the ex-date on 7/15/2024.
When did Ceapro pay the last dividend?
The last dividend was paid out on 7/15/2024.
What was the dividend of Ceapro in the year 2023?
In the year 2023, Ceapro distributed 0 CAD as dividends.
In which currency does Ceapro pay out the dividend?
The dividends of Ceapro are distributed in CAD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Ceapro
Our stock analysis for Ceapro Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ceapro Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
